FastMarket.news

STMicroelectronics Stands by CEO Amid Italian Government Opposition

Published 15 days agoSTM
STMicroelectronics Stands by CEO Amid Italian Government Opposition

STMicroelectronics has reiterated its support for CEO Jean-Marc Chery and his leadership team, despite opposition from the Italian government. The affirmation from the semiconductor giant highlights its confidence in Chery's capabilities to navigate the company through current challenges.


Italy has expressed dissatisfaction with Chery’s leadership, primarily due to difficulties in STMicroelectronics' key markets, such as automotive and industrial segments. According to Yahoo Finance, the Italian government, which holds a significant stake in the company, is also facing resistance against its efforts to appoint Marcello Sala, an official from its economy ministry, to the STMicroelectronics supervisory board.


The company has refuted claims that its management misled investors through strategic share sales prior to releasing negative earnings reports. STMicroelectronics clarified that these transactions occurred during sanctioned blackout periods. This comes amid the company's forecasted revenue drop of 28% in the first quarter, which has intensified the scrutiny surrounding its leadership.

Share this article

Recent Articles

Third Point Acquires Stake in Kenvue Amid Activist Interest

Third Point Acquires Stake in Kenvue Amid Activist Interest

5 minutes agoKVUE

Dan Loeb's hedge fund, Third Point Capital, has acquired a stake in Kenvue, the $43 billion consumer health company behind brands like Tylenol and Neutrogena. According to Insider Monkey, Third Point is the third activist investor in recent months to target Kenvue, following Starboard Value and Toms Capital Investment Management. The specific size of Third Point's stake has not been disclosed, but the move adds to the increasing pressure on Kenvue's management, with speculation around potential takeover or restructuring since its 2023 spin-off from Johnson & Johnson. Earlier this year, Kenvue appointed Starboard's CEO, Jeff Smith, to its board, alongside two other directors, in a strategic move to avoid a proxy clash. Toms Capital has also been advocating for a sale or breakup of the company. Kenvue, despite flat net sales of $15.5 billion, faces competitive challenges in its skincare division from niche brands. Its stock has risen by 8% this year, yet remains near its initial listing price. Third Point shares a history of collaborative activist efforts with Toms, targeting companies like Colgate-Palmolive and Salesforce. Kenvue has indicated its commitment to sustainable growth and enhancing shareholder value.

Tesla Soars 10% Amid Shift in Self-Driving Crash Reporting Rules

Tesla Soars 10% Amid Shift in Self-Driving Crash Reporting Rules

20 minutes agoTSLA

Tesla's stock jumped nearly 10% after the U.S. Transportation Department announced a change in reporting requirements for self-driving vehicles. The new regulation will no longer mandate the reporting of non-fatal crashes involving Level 2 partial self-driving systems, which are prevalent in Tesla's vehicles. This development has fueled investor optimism, propelling Tesla's shares upward. The regulatory shift could significantly impact Tesla's competitive positioning. By not having to report non-fatal incidents, Tesla may present a more favorable safety record compared to competitors, such as Waymo, which must still disclose such data for fully autonomous vehicles. According to AP News, this advantage may enhance Tesla’s market edge as it moves forward with self-driving technologies. Tesla's strategy aligns with these regulatory changes as the company plans to launch self-driving taxis in Austin, Texas. The timing coincides with the U.S. administration's initiative to harmonize self-driving regulations, marking a strategic phase in Tesla's expansion in the autonomous vehicle market. Despite some criticism over potential safety oversight, the move is seen as a positive step for Tesla's operational plans.

Johnson & Johnson Retains 'AAA' Rating Amid $14.6 Billion Acquisition

Johnson & Johnson Retains 'AAA' Rating Amid $14.6 Billion Acquisition

35 minutes agoJNJ

Johnson & Johnson has successfully retained its prestigious 'AAA' credit rating from S&P Global Ratings after a period of uncertainty. The rating agency removed the company from CreditWatch Negative following its $14.6 billion acquisition of Intra-Cellular Therapies, indicating confidence in J&J's strategic financial management. Initially, S&P Global placed J&J on CreditWatch Negative due to concerns about potential increases in leverage that could affect the company's financial stability. The acquisition was expected to raise J&J's adjusted leverage to approximately 1.4 times, surpassing the 1.0 times threshold that typically triggers a rating downgrade. However, projections suggested leverage could decline to 1.1 times by the end of 2025, improving below 1.0 times by late 2026. Despite the initial leverage concerns, Johnson & Johnson's management remains committed to conservative financial practices. The company has a history of successful integration and debt reduction following major acquisitions, underscoring its capability to handle significant financial undertakings while maintaining its strong credit standing. According to Investing.com, the CreditWatch status was resolved after thorough evaluation of J&J's 2024 performance and future financial strategies.

Workday Maintains S&P 'BBB' Credit Rating With Stable Outlook

Workday Maintains S&P 'BBB' Credit Rating With Stable Outlook

50 minutes agoWDAY

As of April 25, 2025, Workday Inc.'s credit rating from S&P Global Ratings remains at 'BBB' with a stable outlook. No recent information suggests an upgrade from this rating, which was assigned on March 29, 2022, and reflects confidence in Workday's growth prospects. Supporting this assessment, Moody's Investors Service granted Workday a Baa2 issuer rating with a stable outlook on March 28, 2022, as reported by Yahoo Finance. Both ratings indicate that Workday is seen as a moderate credit risk with reliable growth performance. Despite recent strong revenue figures and a solid cash position, Workday has not received an upgrade to a 'BBB+' rating from S&P, according to existing reports. This steady rating underscores the company's positioning within the market amid its ongoing business developments.